Skip to content

Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1023-1029
Number of pages7
JournalNutrition, Metabolism and Cardiovascular Diseases
Volume29
Issue number10
Early online date6 Jul 2019
DOIs
DateAccepted/In press - 30 Jun 2019
DateE-pub ahead of print - 6 Jul 2019
DatePublished (current) - 1 Oct 2019

Abstract

Background and aims:
Meta-analyses of randomised controlled trials (RCTs) and observational studies indicate a lower risk of venous thromboembolism (VTE) associated with statin treatment. We aimed to compare the effect of statin therapy in these two settings and to identify and quantify potential factors to explain statin efficacy and effectiveness.

Methods and Results:
We electronically searched on December 11th, 2018, articles reporting on first VTE events in RCTs (statin vs placebo) and in observational studies (participants exposed vs non-exposed to statin). We performed Knapp-Hartung random-effect meta-analyses to calculate pooled relative risks (RRs) of VTE events
associated with statin treatment, separately for RCTs and observational studies; and estimated the ratio of the relative risk (RRR) comparing RCTs vs observational studies using meta-regressions, progressively adjusted for study-level characteristics. Twenty-one RCTs (115,107 participants; 959 events) and 8
observational studies (2,898,096 participants; 19,671 events) were included. Pooled RRs for RCTs and observational studies were 0.82 (95% confidence interval (CI): 0.67 to 1.00; I
2 19.2%) and 0.60 (95% CI: 0.42 to 0.86; I2 86.3%), respectively. In meta-regressions, the unadjusted RRR indicated a nonsignificant
23% smaller benefit in RCTs (RRR 0.77; 95% CI: 0.52 to 1.13); accounting for age, sex, geographical region, and duration of follow-up, there was a sensible change of the RRR which resulted 0.30 (95% CI: 0.13 to 0.68).

Conclusion:
Differences in the characteristics between patients included in RCTs and those in observational studies may account for the differential effect of statins in preventing VTE in the two settings.

    Research areas

  • venous thromboembolism, statin, meta-analysis, meta-regression, clinical trials, observational study, real-world evidence

Documents

Documents

  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the accepted author manuscript (AAM). The final published version (version of record) will be available online via Elsevier at https://www.sciencedirect.com/science/article/pii/S0939475319302650 . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 634 KB, PDF document

    Embargo ends: 6/07/20

    Request copy

    Licence: CC BY-NC-ND

DOI

View research connections

Related faculties, schools or groups